We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical firms can expect to pay on average 7.3 percent more in 2008 for most services provided by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor